Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 16 September 2008, doi:10.1136/bmj.a1668
Cite this as: BMJ 2008;337:a1668
| The first 100% of the full text of this article appears below. |
Grants blanket statement,1 based on the WISDOM study,2 that "it would be irresponsible to think that any use of hormone replacement therapy (HRT) is justifiable" will confuse those dealing with women with early ovarian failure in their 20s and 30s. National guidelines recommend the use of HRT in this group until the average age of the natural menopause in the early 50s.3 The results of the WISDOM study, which randomised women with a mean age of 63.8 years, should not be extrapolated to them.
Cite this as: BMJ 2008;337:a1668
Margaret C P Rees, reader in reproductive medicine, University of Oxford1
1 Womens Centre, John Radcliffe Hospital, Oxford OX3 9DU
margaret.rees@obs-gyn.ox.ac.uk
Read all Rapid Responses